Valley National Advisers Inc Novartis Ag Transaction History

Valley National Advisers Inc

$554 Million
Q3 2024

A detailed history of Valley National Advisers Inc transactions in Novartis Ag stock. As of the latest transaction made, Valley National Advisers Inc holds 9,837 shares of NVS stock, worth $974,846. This represents 0.2% of its overall portfolio holdings.

Number of Shares

9,837

Previous 16,794 41.43%

Holding current value

$974,846

Previous $1.79 Million 36.77%

% of portfolio

0.2%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$106.13 - $120.89 $738,346 - $841,031	-6,957 Reduced 41.43%	9,837 $1.13 Million
Q2 2024 Jul 18, 2024	SELL	$92.57 - $107.37 $32,492 - $37,686	-351 Reduced 2.05%	16,794 $1.79 Million
Q1 2024 Apr 19, 2024	SELL	$95.27 - $108.47 $28,962 - $32,974	-304 Reduced 1.74%	17,145 $1.66 Million
Q4 2023 Jan 25, 2024	SELL	$92.27 - $101.54 $64,589 - $71,078	-700 Reduced 3.86%	17,449 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $105,908 - $117,535	-1,118 Reduced 5.8%	18,149 $1.85 Million
Q2 2023 Jul 31, 2023	SELL	$92.52 - $104.91 $93,352 - $105,854	-1,009 Reduced 4.98%	19,267 $1.95 Million
Q1 2023 Apr 26, 2023	SELL	$80.03 - $92.81 $38,734 - $44,920	-484 Reduced 2.33%	20,276 $2.04 Million
Q4 2022 Jan 12, 2023	SELL	$75.55 - $92.52 $31,655 - $38,765	-419 Reduced 1.98%	20,760 $1.88 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $12,385 - $14,485	-166 Reduced 0.78%	21,179 $1.64 Million
Q2 2022 Jul 15, 2022	BUY	$80.52 - $93.75 $16,184 - $18,843	201 Added 0.95%	21,345 $1.8 Million
Q1 2022 May 06, 2022	SELL	$80.11 - $90.62 $5,207 - $5,890	-65 Reduced 0.31%	21,144 $1.86 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $29,807 - $32,960	-374 Reduced 1.73%	21,209 $1.86 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $7,769 - $9,038	-95 Reduced 0.44%	21,583 $1.77 Million
Q2 2021 Aug 02, 2021	SELL	$85.24 - $94.15 $14,064 - $15,534	-165 Reduced 0.76%	21,678 $1.98 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $30,644 - $36,138	-367 Reduced 1.65%	21,843 $1.87 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $44,890 - $54,297	-575 Reduced 2.52%	22,210 $2.1 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $87,479 - $96,915	-1,065 Reduced 4.47%	22,785 $1.98 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $88,537 - $99,663	-1,094 Reduced 4.39%	23,850 $2.08 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $116,676 - $163,465	-1,651 Reduced 6.21%	24,944 $2.06 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $590 - $667	-7 Reduced 0.03%	26,595 $2.52 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $8,297 - $9,143	-97 Reduced 0.36%	26,602 $2.31 Million
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $36,192 - $44,544	-480 Reduced 1.77%	26,699 $2.44 Million
Q1 2019 Apr 26, 2019	SELL	$75.32 - $86.15 $132,111 - $151,107	-1,754 Reduced 6.06%	27,179 $2.61 Million
Q4 2018 Feb 25, 2019	SELL	$73.66 - $82.02 $22,245 - $24,770	-302 Reduced 1.03%	28,933 $2.48 Million
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $14,860 - $17,189	-222 Reduced 0.75%	29,235 $2.52 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $27,456 - $31,031	-423 Reduced 1.42%	29,457 $2.23 Million
Q1 2018 Apr 19, 2018	SELL	$70.39 - $84.15 $12,810 - $15,315	-182 Reduced 0.61%	29,880 $2.42 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $41,734 - $44,798	-577 Reduced 1.88%	30,062 $2.52 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $2.27 Million - $2.37 Million	30,639	30,639 $2.63 Million

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.

Account

Valley National Advisers Inc Novartis Ag Transaction History